Cochrane Abstracts
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravesical Bacillus Calmette-Guérin Versus Mitomycin C for Ta and T1 Bladder Cancer: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437632/all/Intravesical_Bacillus_Calmette_Guérin_versus_mitomycin_C_for_Ta_and_T1_bladder_cancer:_Cochrane_systematic_review.
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437632/all/Intravesical_Bacillus_Calmette_Guérin_versus_mitomycin_C_for_Ta_and_T1_bladder_cancer:_Cochrane_systematic_review. Accessed March 23, 2025.
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437632/all/Intravesical_Bacillus_Calmette_Guérin_versus_mitomycin_C_for_Ta_and_T1_bladder_cancer:_Cochrane_systematic_review
Intravesical Bacillus Calmette-Guérin Versus Mitomycin C for Ta and T1 Bladder Cancer: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437632/all/Intravesical_Bacillus_Calmette_Guérin_versus_mitomycin_C_for_Ta_and_T1_bladder_cancer:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Cochrane systematic review
ID - 437632
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437632/all/Intravesical_Bacillus_Calmette_Guérin_versus_mitomycin_C_for_Ta_and_T1_bladder_cancer:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
